Press Releases

Oct 18, 2004 Hemispherx Biopharma Comments on Recent Release of Data on Primary Endpoint in Phase III Chronic Fatigue Syndrome Study

Oct 11, 2004 HEMISPHERX BIOPHARMA PRESENTS NEWPHASE III DATA ON AMPLIGEN® AT THE 7th INTERNATIONAL CONFERENCE FOR CHRONIC FATIGUE SYNDROME

Sep 27, 2004 Hemispherx Biopharma to Present New Data on Activity of Ampligen in Treating Chronic Fatigue Syndrome at Annual CFS Conference

Sep 09, 2004 Griffin Securities Initiates Research Coverage of Hemispherx Biopharma With Buy Rating

Sep 07, 2004 HEMISPHERX BIOPHARMA REPORTS COMMENCEMENT OF TREATMENT OF WNV

Aug 10, 2004 HEMISPHERX BIOPHARMA SECOND QUARTER 2004 EARNINGS ANNOUNCED

Aug 06, 2004 HEMISPHERX BIOPHARMA, INC. ANNOUNCES COMPLETION OF PRIVATE PLACEMENT

Aug 05, 2004 Hemispherx Biopharma To Announce Second Quarter Financial Results and to Update Clinical Activities on Wednesday, August 11th

Aug 02, 2004 HEMISPHERX BIOPHARMA TO REPORT NEW DATA ON PIVOTAL PHASE III STUDY IN CFS

Aug 02, 2004 HEMISPHERX BIOPHARMA ANNOUNCES PRIVATE PLACEMENT OF COMMON STOCK AND WARRANTS

58 59 60 61 62 63 64 65 66 67 68

<< < > >>